Status:
RECRUITING
Registry for Systemic Eczema Treatments
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Doris Duke Charitable Foundation
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
1-26 years
Brief Summary
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemi...
Detailed Description
The purpose of the Registry for Systemic Eczema Therapies (RESET) registry is to serve as a database and biospecimen repository of patients with pediatric-onset atopic dermatitis (AD), also known as e...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age \<26 years old
- Current physician diagnosis of atopic dermatitis
- Provide signed informed consent if ≥ 18 years old
- Provide signed informed consent by parent or legal guardian (if \<18 years old) and informed assent if applicable
- Subject and/or parent/legal guardian is willing to be contacted in the future by study staff
- Seen for clinical care at Johns Hopkins since 1/1/2017
- Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy
- Exclusion criteria:
- Age ≥26 years old at the time of registry enrollment
- Does not speak English
- If \<18 years old, has a primary caretaker who does not speak English
- If \<18 years old, parent/legal guardian is unwilling to sign the written informed consent
- Is a foster child
- Has not received clinical care at Johns Hopkins since 1/1/2017
Exclusion
Key Trial Info
Start Date :
January 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06136767
Start Date
January 17 2024
End Date
December 31 2026
Last Update
January 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21218